Related Experiment Video
Updated: May 8, 2026

Simultaneous Laryngopharyngeal and Conventional Esophageal pH Monitoring
Published on: December 14, 2020
Prevalence of pediatric aspiration-associated extraesophageal reflux disease
Insights
Aspiration-associated extraesophageal reflux disease (AERD) is common in children with chronic lung issues. Pepsin in bronchoalveolar lavage fluid is a promising biomarker for AERD, outperforming lipid-laden macrophages.
Area of Science:
- Pulmonology
- Gastroenterology
- Pediatric Medicine
Background:
- The role of aspiration-associated extraesophageal reflux disease (AERD) in pediatric chronic respiratory symptoms remains unclear.
- Identifying AERD prevalence is crucial for guiding treatment strategies in affected children.
Purpose of the Study:
- To determine the prevalence of AERD in pediatric patients presenting with chronic respiratory symptoms.
- To evaluate the diagnostic utility of pepsin as a novel biomarker for AERD.
Main Methods:
- A case-control study was conducted between 2008 and 2012 at a tertiary referral center.
- Bronchoalveolar lavage fluid specimens were analyzed using Western blot for pepsin and oil red O staining for lipid-laden macrophages (LLMs).
- 34 pediatric patients with chronic pulmonary disease and 11 controls were included.
Main Results:
- Pepsin was detected in 74% of patients who underwent bronchoscopy and 71% of patients with tracheostomy.
- Lipid-laden macrophages (LLMs) were present in 91% of the bronchoscopy group and 52% of the tracheostomy group.
- Pepsin was absent in all control specimens, while LLMs were found in 64% of controls.
Conclusions:
- Pediatric patients with chronic pulmonary disease exhibit a high prevalence of AERD, suggesting significant treatment implications.
- Pepsin detection in bronchoalveolar lavage fluid is a more effective predictor of AERD than LLMs in this population.
- Pepsin serves as a valuable biomarker for AERD, potentially offering a superior diagnostic approach compared to LLM analysis.
Importance:
The role of aspiration-associated extraesophageal reflux disease (AERD) in patients with chronic respiratory symptoms is not well defined. Identifying the frequency of AERD in these patients may provide guidance in their treatment.
Objective:
To determine the prevalence of AERD in patients with chronic respiratory symptoms and to assess the utility of pepsin as a new marker for AERD.
Design:
Case-control study performed from 2008 through 2012.Western blot analysis for pepsin and oil red O staining for lipid-laden macrophages (LLMs) was performed on bronchoalveolar lavage fluid specimens.
Setting:
Tertiary referral center.
Participants:
Sixty-five patients (aged 4.5 months to 24 years) with chronic pulmonary disease, with or without tracheostomy, were compared with controls undergoing elective surgery who had no history of pulmonary disease.
Main Outcomes And Measures:
Presence of pepsin and LLMs and quantity of LLMs in specimens.
Results:
Seventy-six total patients participated: 34 patients who underwent bronchoscopy, 31 patients with tracheostomy, and 11 controls. Pepsin-positive bronchoalveolar lavage fluid specimens were identified in 25 patients who underwent bronchoscopy (74%) and 22 patients with tracheostomy (71%). All specimens from controls were negative for pepsin. Presence of LLMs was identified in specimens from 31 patients in the bronchoscopy group (91%), 16 patients in the tracheostomy group (52%), and 7 controls (64%), with a similar distribution of the quantity of LLMs in each lavage fluid specimen among the groups.
Conclusions And Relevance:
Patients with chronic pulmonary disease have a high prevalence of AERD, which may have important treatment implications. The presence of pepsin was a better predictor of AERD in patients with respiratory symptoms compared with controls than presence of LLMs. Detection of pepsin in bronchoalveolar lavage fluid specimens can serve as a biomarker for AERD and is potentially superior to the current method of measuring LLMs. Whereas there is a significant association between AERD and the presence of chronic respiratory symptoms, this study does not verify causation. Additional study investigating the mechanism of pepsin on the respiratory epithelium may further our understanding of the pathophysiologic characteristics of this association and provide additional management options for these patients.
Related Concept Videos
Gastroesophageal Reflux Disease
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology
Esophageal Achalasia
Barrett Esophagus-I: Introduction
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...

